И. Р. Кулмагамбетов
Research and Production Center of Microbiology and Virology · 36 works · 118 citations · h-index 5
Top works
- Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
- Pharmacy and pharmacists' perceptions of pharmaceutical care in Kazakhstan
- Efficacy and Safety of an Inactivated Whole-Virion Vaccine Against COVID-19, QazCovid-in®, In Healthy Adults: A Multicentre, Randomised, Single-Blind, Placebo-Controlled Phase 3 Clinical Trial With a 6-Month Follow-Up
- Safety and immunogenicity of the novel seasonal preservative‐ and adjuvant‐free influenza vaccine: Blind, randomized, and placebo‐controlled trial
- NEW ORIGINAL DRUG ROSEOFUNGIN-AS, OINTMENT 2%
- Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults
- STAGES OF TECHNOLOGY TRANSFER IN THE DEVELOPMENT OF PHARMACEUTICAL PRODUCTION
- CHARACTERISTICS FOR ANTIBIOTIC SUSCEPTIBILITY OF STRAINS OF MICROORGANISMS ISOLATED IN THE NORTHERN REGION OF THE REPUBLIC OF KAZAKHSTAN (CITIES OF PETROPAVLOVSK, KOSTANAI)
- First Phase of the Clinical trial of the AS-Probionorm Probiotic Medication for the treatment of Human Intestinal Infections
- Safety and Immunogenicity of a QazCovid-in® Inactivated Whole-Virion Vaccine Against COVID-19 in Healthy Adults: A Randomized, Single-Blind, Placebo-Controlled Phase 1 Clinical Trial with a 6 Months Follow-Up and an Open-Label Phase 2 Clinical Trial in Kazakhstan
- Pharmaco-Technological Characterization, Structural Analysis, and Toxicological Evaluation of the Novel Polyene Antibiotic Roseofungin for Drug Development
- ROSEOFUNGIN-AS, OINTMENT 2% FOR TREATMENT OF TINEA PEDIS AND TINEA CORPORIS: RESULTS OF A RANDOMIZED, BLINDED, PROSPECTIVE, MULTICENTER PHASE III CLINICAL TRIAL
- ПОЛИЕНОВЫЕ АНТИБИОТИКИ, ИСПОЛЬЗУЕМЫЕ В ПРОТИВОГРИБКОВОЙ ТЕРАПИИ
- Межкафедральные лаборатории – основа для развития взаимосвязи медицинского образования и науки
- Перспективы оптимизации эмпирической антибактериальной терапии: мониторинг локальной антибиотикорезистентности
- SAFETY AND TOLERABILITY RESEARCH OF THE NEW DRUG CANPROFEM-AK FOR THE TREATMENT OF CANDIDAL VAGINAL INFECTIONS (PHASE 1)
- Новые направления тестирования лекарственных средств с использованием плюрипотентных стволовых клеток
- Особенности образовательных программ додипломной подготовки врачей
- Design of medical information system for dynamic control
- Современные подходы к контролю и сдерживанию антибиотикорезистентности в мире